437 related articles for article (PubMed ID: 26390359)
1. Polylactide-based Magnetic Spheres as Efficient Carriers for Anticancer Drug Delivery.
Mhlanga N; Sinha Ray S; Lemmer Y; Wesley-Smith J
ACS Appl Mater Interfaces; 2015 Oct; 7(40):22692-701. PubMed ID: 26390359
[TBL] [Abstract][Full Text] [Related]
2. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
Elbialy NS; Fathy MM; Khalil WM
Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
[TBL] [Abstract][Full Text] [Related]
4. Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries.
Li Z; Yuan D; Jin G; Tan BH; He C
ACS Appl Mater Interfaces; 2016 Jan; 8(3):1842-53. PubMed ID: 26717323
[TBL] [Abstract][Full Text] [Related]
5. Folic acid conjugated Fe
Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
[TBL] [Abstract][Full Text] [Related]
6. A multi-controlled drug delivery system based on magnetic mesoporous Fe
Zhang Q; Liu J; Yuan K; Zhang Z; Zhang X; Fang X
Nanotechnology; 2017 Oct; 28(40):405101. PubMed ID: 28837053
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization.
Li G; Cao L; Zhou Z; Chen Z; Huang Y; Zhao Y
Colloids Surf B Biointerfaces; 2015 Apr; 128():379-388. PubMed ID: 25779605
[TBL] [Abstract][Full Text] [Related]
8. Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.
Samra ZQ; Ahmad S; Javeid M; Dar N; Aslam MS; Gull I; Ahmad MM
Prep Biochem Biotechnol; 2013; 43(8):781-97. PubMed ID: 23876138
[TBL] [Abstract][Full Text] [Related]
9. Investigation of novel superparamagnetic Ni
Qasim M; Asghar K; Dharmapuri G; Das D
Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-modified PAMAM-Fe3O4-doxorubicin triads with the potential for improved therapeutic efficacy: generation-dependent increased drug loading and retention at neutral pH and increased release at acidic pH.
Nigam S; Chandra S; Newgreen DF; Bahadur D; Chen Q
Langmuir; 2014 Feb; 30(4):1004-11. PubMed ID: 24446987
[TBL] [Abstract][Full Text] [Related]
11. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
Yu Y; Chen CK; Law WC; Weinheimer E; Sengupta S; Prasad PN; Cheng C
Biomacromolecules; 2014 Feb; 15(2):524-32. PubMed ID: 24446700
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of magnetic NaX zeolite/DOX into the PLA/chitosan nanofibers for sustained release of doxorubicin against carcinoma cells death in vitro.
Abasian P; Radmansouri M; Habibi Jouybari M; Ghasemi MV; Mohammadi A; Irani M; Jazi FS
Int J Biol Macromol; 2019 Jan; 121():398-406. PubMed ID: 30287373
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Abbasi Aval N; Pirayesh Islamian J; Hatamian M; Arabfirouzjaei M; Javadpour J; Rashidi MR
Int J Pharm; 2016 Jul; 509(1-2):159-167. PubMed ID: 27234695
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Fe
Xu Y; Shan Y; Zhang Y; Yu B; Shen Y; Cong H
Nanotechnology; 2019 Oct; 30(42):425102. PubMed ID: 31261137
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.
Sadighian S; Rostamizadeh K; Hosseini-Monfared H; Hamidi M
Colloids Surf B Biointerfaces; 2014 May; 117():406-13. PubMed ID: 24675279
[TBL] [Abstract][Full Text] [Related]
16. Magnetic targeted drug delivery carriers encapsulated with pH-sensitive polymer: synthesis, characterization and in vitro doxorubicin release studies.
Wu J; Shen Y; Jiang W; Jiang W; Shen Y
J Biomater Sci Polym Ed; 2016 Sep; 27(13):1303-16. PubMed ID: 27252073
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and correction of albumin magnetic nanoparticles with organic compounds for absorbing and releasing doxorubicin hydrochloride.
Hormozi N; Esmaeili A
Colloids Surf B Biointerfaces; 2019 Oct; 182():110368. PubMed ID: 31362156
[TBL] [Abstract][Full Text] [Related]
18. Glutamic acid-coated Fe
Dutta B; Nema A; Shetake NG; Gupta J; Barick KC; Lawande MA; Pandey BN; Priyadarsini IK; Hassan PA
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110915. PubMed ID: 32409067
[TBL] [Abstract][Full Text] [Related]
19. Intelligent anticancer drug delivery performances of two poly(N-isopropylacrylamide)-based magnetite nanohydrogels.
Poorgholy N; Massoumi B; Ghorbani M; Jaymand M; Hamishehkar H
Drug Dev Ind Pharm; 2018 Aug; 44(8):1254-1261. PubMed ID: 29452515
[TBL] [Abstract][Full Text] [Related]
20. Kinetic models for the release of the anticancer drug doxorubicin from biodegradable polylactide/metal oxide-based hybrids.
Mhlanga N; Ray SS
Int J Biol Macromol; 2015 Jan; 72():1301-7. PubMed ID: 25450549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
